SCHEMBL805266

SCHEMBL805266

CCC(C)C(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24221648 1.00 NPSR1 (0.37)
SCHEMBL19012246 1.00
SCHEMBL12838113 1.00
SCHEMBL18494027 0.93 NPSR1 (0.34)
SCHEMBL3787105 0.91 POLB (0.38)
SCHEMBL22313529 0.89 SMYD3 (0.40)
SCHEMBL3449442 0.89 EPHX2 (0.42)
SCHEMBL8224071 0.89 EPHX2 (0.42)
SCHEMBL18052223 0.86 MMP1 (0.32)
SCHEMBL19871738 0.85 GABRP (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065676-A1 COMBINATION THERAPIES COMPRISING PAR1 ANTAGONISTS WITH NAR AGONISTS SCHERING CORPORATION (US) 2011-03-17 US disclosed
WO-2008074403-A2 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS BAYER CROPSCIENCE AG (DE) 2008-06-26 WO disclosed
EP-1500657-B1 Substituted pyrazoles as P38 kinase inhibitors SEARLE LLC (US) 2007-09-19 EP disclosed